None of the estimates for this Home Health Care stock were revised over the past 30 days. The Zacks Consensus Estimate also remained unchanged over the same time frame. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Amedisys currently has a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%.
Some better-ranked stocks in the health care sector include AmSurg Corp. (AMSG), RadNet, Inc. (RDNT) and U.S. Physical Therapy Inc. (USPH), each sporting a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment